Package 31722-568-60

{"route": ["ORAL"], "spl_id": "06f285d0-a267-615d-e063-6394a90a68ff", "openfda": {"nui": ["N0000000246", "N0000175889", "N0000190114", "N0000182137"], "upc": ["0331722568609"], "unii": ["YO603Y8113"], "rxcui": ["670026", "824338"], "spl_set_id": ["64160982-e682-4e8d-8800-a89321112211"], "pharm_class_epc": ["Protease Inhibitor [EPC]"], "pharm_class_moa": ["HIV Protease Inhibitors [MoA]", "Cytochrome P450 3A Inhibitors [MoA]", "Cytochrome P450 2D6 Inhibitors [MoA]"], "manufacturer_name": ["Camber Pharmaceuticals, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "60 TABLET, FILM COATED in 1 BOTTLE (31722-568-60)", "package_ndc": "31722-568-60", "marketing_start_date": "20230914"}], "brand_name": "Darunavir", "product_id": "31722-568_06f285d0-a267-615d-e063-6394a90a68ff", "dosage_form": "TABLET, FILM COATED", "pharm_class": ["Cytochrome P450 2D6 Inhibitors [MoA]", "Cytochrome P450 3A Inhibitors [MoA]", "HIV Protease Inhibitors [MoA]", "Protease Inhibitor [EPC]"], "product_ndc": "31722-568", "generic_name": "Darunavir", "labeler_name": "Camber Pharmaceuticals, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Darunavir", "active_ingredients": [{"name": "DARUNAVIR", "strength": "600 mg/1"}], "application_number": "ANDA202083", "marketing_category": "ANDA", "marketing_start_date": "20230914", "listing_expiration_date": "20261231"}